BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26662402)

  • 1. Association of tumor necrosis factor-α 308G/A polymorphism with urogenital cancer risk: a systematic review and meta-analysis.
    Cai J; Yang MY; Hou N; Li X
    Genet Mol Res; 2015 Dec; 14(4):16102-12. PubMed ID: 26662402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tumor necrosis factor-α-308G/A gene polymorphism and susceptibility to pre-eclampsia: An updated meta-analysis.
    Wang L; Qu G; Wu W; Tang X; Sun Y
    Cytokine; 2018 Nov; 111():278-286. PubMed ID: 30245306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the TNF-α-308G/A polymorphism and vitiligo risk.
    Nie G; Qi JH; Huang CW; Yang T; Shi N; Chen YJ
    Genet Mol Res; 2015 Dec; 14(4):17296-304. PubMed ID: 26681224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α-308G/A polymorphism and the risk of colorectal cancer: A systematic review and an updated meta-analysis.
    Miao Z; Wang K; Wang X; Zhang C; Xu Y
    J BUON; 2018; 23(6):1616-1624. PubMed ID: 30610785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between TNF-α gene 308G>A polymorphism and lung cancer risk: a meta-analysis.
    Xie H; Yao H; Huo Y; Li N; Cheng Y
    Tumour Biol; 2014 Oct; 35(10):9693-9. PubMed ID: 24969564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-α gene 308G/A polymorphism is not associated with esophageal squamous cell carcinoma risk in Kazakh patients.
    Cui XB; Wang DD; Zhang HY; Li TT; Jin TT; Peng H; Zhang SM; Wang B; Yu J; Liu CX; Yang L; Jin J; Li S; Jiang JF; Liang WH; Hu JM; Li SG; Wu CY; Chen YZ; Li F
    Int J Clin Exp Pathol; 2015; 8(8):9293-9. PubMed ID: 26464679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor (TNF)-α -308G/A (rs1800629) polymorphism distribution in North India and its association with pemphigus: Case-control study and meta-analysis.
    Dar SA; Akhter N; Haque S; Singh T; Mandal RK; Ramachandran VG; Bhattacharya SN; Banerjee BD; Das S
    Autoimmunity; 2016; 49(3):179-87. PubMed ID: 26761187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis.
    Yuan C; Xu XH; Xu L; Liu Y; Sun M; Ni LH; Wang XL; Chen Z; Zhang K; Zeng G
    Medicine (Baltimore); 2017 Jun; 96(25):e7298. PubMed ID: 28640146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. -308G/A polymorphism of tumor necrosis factor alpha (TNF-α) gene and metabolic syndrome susceptibility: a meta-analysis.
    Wang D; He L; Zhang X
    Sci Rep; 2021 Feb; 11(1):3840. PubMed ID: 33589701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α-308G/A polymorphism contributes to obstructive sleep apnea syndrome risk: evidence based on 10 case-control studies.
    Wu Y; Cao C; Wu Y; Zhang C; Zhu C; Ying S; Chen Z; Shen H; Li W
    PLoS One; 2014; 9(9):e106183. PubMed ID: 25192323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-α (TNF-α) -308G >a promoter polymorphism (rs1800629) promotes Asians in susceptibility to Plasmodium falciparum severe malaria: A meta-analysis.
    Kongjam P; Pabalan N; Tharabenjasin P; Jarjanazi H; Chaijaroenkul W; Na-Bangchang K
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011735. PubMed ID: 37910577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tumor necrosis factor-α-308G/A polymorphism with the risk of obstructive sleep apnea: A meta-analysis of 14 case-control studies.
    Zhang Z; Duolikun D; Dang T; Wang Y; Ma L; Ma X; Yao Q
    PLoS One; 2023; 18(8):e0290239. PubMed ID: 37595008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha-308 gene promoter polymorphism associates with survival of cancer patients: A meta-analysis.
    Yi F; Shi X; Pei X; Wu X
    Medicine (Baltimore); 2018 Nov; 97(45):e13160. PubMed ID: 30407345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TNF-α -308G>A Polymorphism with Susceptibility to Cervical Cancer and Breast Cancer - a Systematic Review and Meta-analysis.
    Farbod M; Karimi MZ; Heiranizadeh N; Seifi NS; Akbarian JBM; Jarahzadeh HM; Neamatzadeh H
    Klin Onkol; 2019; 32(3):170-180. PubMed ID: 31216848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The single-nucleotide polymorphism (SNP) of tumor necrosis factor α -308G/A gene is associated with early-onset primary knee osteoarthritis in an Egyptian female population.
    Abdel Galil SM; Ezzeldin N; Fawzy F; El-Boshy M
    Clin Rheumatol; 2017 Nov; 36(11):2525-2530. PubMed ID: 28695434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between TNF-α and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis.
    Wu H; Yu K; Yang Z
    J Assist Reprod Genet; 2015 Apr; 32(4):625-34. PubMed ID: 25690158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
    Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
    Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Necrosis Factor Alpha-308G/A Polymorphism and the Risk of Multiple Myeloma: A Meta-Analysis of Pooled Data from Twelve Case-Control Studies.
    Li Y; Lin Y
    Turk J Haematol; 2019 May; 36(2):72-80. PubMed ID: 30600678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-α-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis.
    Xie L; Liang XN; Deng Y; Qin X; Li S
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1667-72. PubMed ID: 23183825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of TNF-α -308G/A and -238G/A polymorphisms with type 2 diabetes mellitus: a meta-analysis.
    Guo X; Li C; Wu J; Mei Q; Liu C; Sun W; Xu L; Fu S
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.